-
Mashup Score: 6
Reducing prasugrel to 5 mg at 1 month makes sense, especially in those at higher risk for bleeding, says Allen Jeremias.
Source: TCTMD.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 16
Read the latest articles of Journal of the American College of Cardiology at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet-
#TCT2021 #cardiotwitter “Coronary Microvascular Dysfunction in #Takotsubo Cardiomyopathy Assessed by #IMRangio" @jgranadacrf @TCTConference @SOCiME_ @CiticMexico @PCRonline @TCTMD @CRT_meeting @sbrugaletta @Ortega_Paz @INC_CathLab https://t.co/Q9uGiQO8ad https://t.co/tKyxJNQCOm
-
#TCT2021 #cardiotwitter “Real-World Experience With the New Watchman FLX Device" @jgranadacrf @TCTConference @SOCiME_ @CiticMexico @PCRonline @TCTMD @CRT_meeting @sbrugaletta @Ortega_Paz @INC_CathLab https://t.co/Q9uGiQO8ad https://t.co/kYMBMHOpDb
-
#TCT2021 #cardiotwitter “Impact of Coronary CT Image Quality on the Accuracy of the #FFRCT Planner to Predict #FFR After #PCI" @jgranadacrf @TCTConference @SOCiME_ @CiticMexico @PCRonline @TCTMD @CRT_meeting @sbrugaletta @Ortega_Paz @INC_CathLab https://t.co/Q9uGiQO8ad https://t.co/kmP6uXoGeh
-
#TCT2021 #cardiotwitter “#Prasugrel or #Clopidogrel in Patients (19,914) With #ACS With Multivessel Disease" @jgranadacrf @TCTConference @SOCiME_ @CiticMexico @PCRonline @TCTMD @CRT_meeting @sbrugaletta @Ortega_Paz @INC_CathLab https://t.co/Q9uGiQO8ad https://t.co/fFDe3FDBPZ
-
#TCT2021 #cardiotwitter “The #CTA–Derived Plaque Burden and Low-Attenuation Plaque According to #FFR Range in #DM" @jgranadacrf @TCTConference @SOCiME_ @CiticMexico @PCRonline @TCTMD @CRT_meeting @sbrugaletta @Ortega_Paz @INC_CathLab https://t.co/Q9uGiQO8ad https://t.co/xjGzmBTGtf
-
-
Mashup Score: 49
Read the latest articles of Journal of the American College of Cardiology at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet-
#TCT2021 #cardiotwitter "#SYNTAX Extended: >70yo pt w 3VD or LMD had comparable 10y all-cause death rate irrespective of revasc mode" @jgranadacrf @TCTConference @SOCiME_ @CiticMexico @PCRonline @TCTMD @CRT_meeting @sbrugaletta @Ortega_Paz @INC_CathLab https://t.co/Q9uGiQO8ad https://t.co/qbQd85viOR
-
#TCT2021 #cardiotwitter "#FlowTriever: favorable procedural safety profile, on table hemodynamic & positive long-term outcomes." @jgranadacrf @TCTConference @SOCiME_ @CiticMexico @PCRonline @TCTMD @CRT_meeting @sbrugaletta @Ortega_Paz @INC_CathLab https://t.co/Q9uGiQwwLD https://t.co/ZaSjypUYvo
-
#TCT2021 #cardiotwitter "SMART-RESCUE score is a highly predictive predictive model on pts w RICS requiring ECMO insertion" @jgranadacrf @TCTConference @SOCiME_ @CiticMexico @PCRonline @TCTMD @CRT_meeting @sbrugaletta @Ortega_Paz @INC_CathLab https://t.co/Q9uGiQO8ad https://t.co/GCesfgNX6r
-
#TCT2021 #cardiotwitter #Examination-Extend Trial "#diabetics had worse clinical outcomes 10 years after #STEMI vs nondiabetics" @jgranadacrf @TCTConference @SOCiME_ @CiticMexico @PCRonline @TCTMD @CRT_meeting @sbrugaletta @Ortega_Paz @INC_CathLab https://t.co/Q9uGiQO8ad https://t.co/txAcHv4KmX
-
#TCT2021 #cardiotwitter "In #ACS complex #PCI, #prasugrel based de-escalation vs conventional rx reduced the risk of bleeding" @jgranadacrf @TCTConference @SOCiME_ @CiticMexico @PCRonline @TCTMD @CRT_meeting @sbrugaletta @Ortega_Paz @INC_CathLab https://t.co/Q9uGiQO8ad https://t.co/0vTFSSBAE4
-
#TCT2021 #cardiotwitter "After DAPT, clopidogrel monorx ⏬ the 2y EP of all-cause death, MI, & stroke in pts w DM compared w ASA" @jgranadacrf @TCTConference @SOCiME_ @CiticMexico @PCRonline @TCTMD @CRT_meeting @sbrugaletta @Ortega_Paz @INC_CathLab https://t.co/Q9uGiQO8ad https://t.co/WEctZgdl9n
-
#TCT2021 #cardiotwitter "BP remains uncontrolled in 40-60% of patients w hypertension despite GDMT " @jgranadacrf @TCTConference @SOCiME_ @CiticMexico @PCRonline @TCTMD @CRT_meeting @sbrugaletta @Ortega_Paz @INC_CathLab @AnastasiaSMihai https://t.co/Q9uGiQwwLD https://t.co/TNEcC3t5ey
-
#TCT2021 #cardiotwitter "Cumulative medical #cost after index was lower following #FFR-guided PCI than angiography guided PCI" @jgranadacrf @TCTConference @SOCiME_ @CiticMexico @PCRonline @TCTMD @CRT_meeting @sbrugaletta @Ortega_Paz @INC_CathLab https://t.co/Q9uGiQO8ad https://t.co/4DSZ8rGCC1
-
#TCT2021 #cardiotwitter "#Backbeat CNT significantly reduces SBP and PP wo affecting DBP, ..." @jgranadacrf @TCTConference @SOCiME_ @CiticMexico @PCRonline @TCTMD @CRT_meeting @sbrugaletta @Ortega_Paz @INC_CathLab https://t.co/Q9uGiQwwLD https://t.co/7Z4Jz4hzen
-
#TCT2021 #cardiotwitter "#COAPT: improvement of LVGLS at 6m fu was assoc w lower subsequent risk of death and HFH in both arms." @jgranadacrf @TCTConference @SOCiME_ @CiticMexico @PCRonline @TCTMD @CRT_meeting @sbrugaletta @Ortega_Paz @INC_CathLab https://t.co/Q9uGiQwwLD https://t.co/3oagYCRSlS
-
#TCT2021 #cardiotwitter "#IVL was associated with low rates of 1-year TLR and late ST in severely calcified coronary lesions" @jgranadacrf @TCTConference @SOCiME_ @CiticMexico @PCRonline @TCTMD @CRT_meeting @sbrugaletta @Ortega_Paz @INC_CathLab https://t.co/Q9uGiQwwLD
-
-
Mashup Score: 11Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome in Relation to Estimated Glomerular Filtration Rate: - 3 year(s) ago
Abstract Objectives The aim of this study was to assess the safety and efficacy of ticagrelor versus prasugrel for patients with acute coronary syndrome (ACS) according to their estimated glomerula…
Categories: Cardiology News and Journals, Latest HeadlinesTweet-
In #cvMI, does the eGFR impact the efficacy and safety of #ticagrelor vs. #prasugrel? Read more about this analysis from the ISAR-REACT 5 trial. https://t.co/LXaNsRwSDS #JACCINT #ACCIntl #CardioTwitter #cvACS #PCI https://t.co/RyPVjRFiLQ
-
-
Mashup Score: 1Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome in Relation to Estimated Glomerular Filtration Rate: - 3 year(s) ago
Abstract Objectives The aim of this study was to assess the safety and efficacy of ticagrelor versus prasugrel for patients with acute coronary syndrome (ACS) according to their estimated glomerula…
Categories: Cardiology News and Journals, Latest HeadlinesTweet-
#ESCCongress #JACCINT SimPub: ISAR-REACT V trial - the reduction of eGFR has no significant impact on the relative efficacy and safety of #ticagrelor vs. #prasugrel. https://t.co/XWiCEMUypC #PCI #CardioTwitter #MedTwitter #cvCKD https://t.co/KnijQyeHd8
-
-
Mashup Score: 7Meta-Analysis Comparing the Safety and Efficacy of Prasugrel and Ticagrelor in Acute Coronary Syndrome - 3 year(s) ago
Prasugrel and ticagrelor are preferred over clopidogrel for patients with acute coronary syndrome who underwent percutaneous coronary intervention. We sought to determine the relative merits of 1 agent over the other. Multiple databases were queried to identify relevant randomized control trials (RCTs) and observational cohort studies. Random-effects model was used to calculate an unadjusted odds…
Source: American Journal of CardiologyCategories: Cardiologists, Latest HeadlinesTweet-
RT @SABOURETCardio: #MetaAnalysis Comparing the Safety and Efficacy of #Prasugrel and #Ticagrelor in #ACS #DAPT https://t.co/NLPa9NfR76
-
-
Mashup Score: 10Meta-Analysis Comparing the Safety and Efficacy of Prasugrel and Ticagrelor in Acute Coronary Syndrome - 3 year(s) ago
Prasugrel and ticagrelor are preferred over clopidogrel for patients with acute coronary syndrome who underwent percutaneous coronary intervention. We sought to determine the relative merits of 1 agent over the other. Multiple databases were queried to identify relevant randomized control trials (RCTs) and observational cohort studies. Random-effects model was used to calculate an unadjusted odds…
Source: American Journal of CardiologyCategories: Cardiologists, Latest HeadlinesTweet-
RT @SABOURETCardio: #MetaAnalysis Comparing the Safety and Efficacy of #Prasugrel and #Ticagrelor in #ACS #DAPT https://t.co/NLPa9NfR76
-
-
Mashup Score: 9Meta-Analysis Comparing the Safety and Efficacy of Prasugrel and Ticagrelor in Acute Coronary Syndrome - 3 year(s) ago
Prasugrel and ticagrelor are preferred over clopidogrel for patients with acute coronary syndrome who underwent percutaneous coronary intervention. We sought to determine the relative merits of 1 agent over the other. Multiple databases were queried to identify relevant randomized control trials (RCTs) and observational cohort studies. Random-effects model was used to calculate an unadjusted odds…
Source: American Journal of CardiologyCategories: Cardiologists, Latest HeadlinesTweet-
RT @SABOURETCardio: #MetaAnalysis Comparing the Safety and Efficacy of #Prasugrel and #Ticagrelor in #ACS #DAPT https://t.co/NLPa9NfR76
-
-
Mashup Score: 5
The objective of this study was to provide descriptive statistics on patterns of prasugrel usage in the outpatient setting in France. This retrospective study was conducted to describe treatment patterns for prasugrel in the outpatient setting in France …
Source: PubMed Central (PMC)Categories: Cardiologists, Latest HeadlinesTweet-
#Prasugrel Use in #RealLife : A Report From the Outpatient Setting in France. #DAPT https://t.co/DXxaY2ZAVj
-
-
Mashup Score: 3Clopidogrel, prasugrel, and ticagrelor for all-comers with ST-segment elevation myocardial infarction - PubMed - 3 year(s) ago
Among all-comers with STEMI, ticagrelor and prasugrel were associated with reduced incidence of the composite end point of all-cause mortality, recurrent myocardial infarction, and ischemic stroke without an increase in bleedings leading to hospitalization compared with clopidogrel. No differences w …
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet-
#P2Y12i for all-comers with ST-segment elevation myocardial infarction - No difference btw #prasugrel and #ticagrelor https://t.co/z27rtwwy1S
-
One more proof advocating #DAPT De-escalation #Prasugrel Reduces Net Events in Complex #PCI for #ACS https://t.co/7w6FzI2LKs